Bio-FD&C Co

Bio-FD&C Co EBIT per Share

The EBIT per Share of Bio-FD&C Co (251120.KQ) as of Nov 16, 2026 is 733.12 KRW. In the previous year, EBIT per Share was 568.95 KRW — a change of 28.85% (higher).

EBIT per Share

733.12KRW

YoY

28.85%

Last updated:

EBIT per Share of Bio-FD&C Co is 2025 733.12 KRW. EBIT per Share of Bio-FD&C Co was 2024 568.95 KRW. It decreases by 28.85% higher compared to the previous year.

The Bio-FD&C Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
336.34 KRW
Jan 1, 2021
424.24 KRW
Jan 1, 2022
572.24 KRW
Jan 1, 2023
590.23 KRW
Jan 1, 2024
568.95 KRW
Jan 1, 2025
733.12 KRW
Jan 1, 2026 (e)
926.02 KRW
Jan 1, 2027 (e)
1,136.83 KRW
The Bio-FD&C Co EBIT per Share history
YEAREBIT per ShareYoY
est1,136.83KRW+22.77%
est926.02KRW+26.31%
733.12KRW+28.85%
568.95KRW-3.60%
590.23KRW+3.14%
572.24KRW+34.89%
424.24KRW+26.13%
336.34KRW+0.93%
333.24KRW+1,115.04%
27.43KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

EBIT per Share of Bio-FD&C Co is 733.12 KRW in 2025.

EBIT per Share of Bio-FD&C Co changed from 568.95 KRW to 733.12 KRW, representing a 28.85% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Bio-FD&C Co

All Key Metrics — Bio-FD&C Co